000 01387 a2200397 4500
005 20250514023311.0
264 0 _c20020716
008 200207s 0 0 eng d
022 _a0903-1936
024 7 _a10.1183/09031936.01.00216501
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aO'Donnell, D E
245 0 0 _aEvaluation of bronchodilator responses in patients with "irreversible" emphysema.
_h[electronic resource]
260 _bThe European respiratory journal
_cDec 2001
300 _a914-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAlbuterol
_xtherapeutic use
650 0 4 _aBronchodilator Agents
_xtherapeutic use
650 0 4 _aEmphysema
_xcomplications
650 0 4 _aFemale
650 0 4 _aForced Expiratory Volume
650 0 4 _aFunctional Residual Capacity
650 0 4 _aHumans
650 0 4 _aInspiratory Capacity
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPulmonary Disease, Chronic Obstructive
_xcomplications
650 0 4 _aSeverity of Illness Index
650 0 4 _aTotal Lung Capacity
650 0 4 _aVital Capacity
700 1 _aForkert, L
700 1 _aWebb, K A
773 0 _tThe European respiratory journal
_gvol. 18
_gno. 6
_gp. 914-20
856 4 0 _uhttps://doi.org/10.1183/09031936.01.00216501
_zAvailable from publisher's website
999 _c11738542
_d11738542